Products for Research Use Only
RegisterLogin

GSK1362

CAT: 0804-HY-176851-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-176851-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
GSK1362 is a selective inverse agonist of REV-ERB. GSK1362disrupts the interaction of REV-ERBα with repressive co-modulators (NCoR1, SMRT2, RIP140). GSK1362 exerts an inverse agonist effect by increasing the transcription of BMAL1 to relieve BMAL1 repression by endogenous REV-ERB ligands. GSK1362 suppresses LPS -induced inflammatory cytokine expression, inhibits IL-1β-induced Cxcl5 transcription in cells. GSK1362 can be used for the study of inflammatory diseases[1].
CAS Number
2986733-57-5
UNSPSC
12352005
Target
REV-ERB
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Field of Research
Inflammation/Immunology
Purity
96.38
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
N#CC1=C(NCCOC)OC(C2=CC=C(N(CC3=CC=C(C=C3)Cl)C)C=C2)=N1
Molecular Formula
C21H21ClN4O2
Molecular Weight
396.87
References & Citations
[1]Pariollaud M, et al. Circadian clock component REV-ERBα controls homeostatic regulation of pulmonary inflammation. J Clin Invest. 2018 Jun 1;128 (6) :2281-2296.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-111049GSK8062
HY-148631GSK137
HY-103028-01GSK962
HY-13470-01GSK126
HY-120343-01GSK106
HY-145347GSK232

Alternative Products

CatalogName
GTR19272894-01GSK1362

Popular Products